U.S. Markets closed

Hospital Acquired Infection (HAI) Control Markets 2010-2021 - Research and Markets


Research and Markets has announced the addition of the "Hospital Acquired Infection (HAI) Control Markets" report to their offering.

Hospital Acquired Infection (HAI) Control Markets provides a revenue analysis for the prevention, testing, and treatment of infections in the healthcare surroundings, including the world revenues for 2010-2021 for hospital infection control, for hospital infection treatment, and for hospital infection prevention equipment and consumables (sterilization/disinfection).

Sales information is also provided for the different market segments by primary geographic region (United States, Europe, rest of world) and leading manufacturers' shares.

Merck, Pfizer, GlaxoSmithKline, and Bayer are among the key companies in HAI control markets are among those manufacturers featured in the report's competitor analysis.

Key Topics Covered:

Chapter One: Executive Summary

Chapter Two: Introduction And Industry Trends

Chapter Three: Infection Prevention

Chapter Four: Infection Testing

Chapter Five: Infection Treatment

Chapter Six: Market Opportunities For Hospital Infection Control

Chapter Seven: Company Profiles

  • 3M
  • Abbott Laboratories
  • Abbvie
  • Alere
  • Astrazeneca
  • Bayer
  • Becton, Dickinson And Company
  • Belimed
  • Biomérieux S.A.
  • Cantel Medical Corp.
  • Danaher Corporation
  • Ecolab, Inc.
  • Getinge Group
  • Glaxosmithkline Plc
  • Merck & Co.
  • Pfizer, Inc.
  • Roche
  • Sakura Seiki Co., Ltd.
  • Steris Plc
  • Tso3, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/g8kr65/hospital_acquired

View source version on businesswire.com: http://www.businesswire.com/news/home/20170321005776/en/